Literature DB >> 24976902

Pathological factors affecting gastric adenocarcinoma survival in a Caribbean population from 2000-2010.

Patrick O Roberts1, Joseph Plummer1, Pierre-Anthony Leake1, Shane Scott1, Tamara G de Souza1, Ayesha Johnson1, Tracey N Gibson1, Barrie Hanchard1, Marvin Reid1.   

Abstract

AIM: To investigate pathological factors related to long term patient survival post surgical management of gastric adenocarcinoma in a Caribbean population.
METHODS: This is a retrospective, observational study of all patients treated surgically for gastric adenocarcinoma from January 1(st) 2000 to December 31(st) 2010 at The University Hospital of the West Indies, an urban Jamaican hospital. Pathological reports of all gastrectomy specimens post gastric cancer resection during the specified interval were accessed. Patients with a final diagnosis other than adenocarcinoma, as well as patients having undergone surgery at an external institution were excluded. The clinical records of the selected cohort were reviewed. The following variables were analysed; patient gender, patient age, the number of gastrectomies previous performed by the lead surgeon, the gross anatomical location and appearance of the tumour, the histological appearance of the tumour, infiltration of the tumour into stomach wall and surrounding structures, presence of Helicobacter pylori and the presence of gastritis. Patient status as dead vs alive was documented for the end of the interval. The effect of the aforementioned factors on patient survival were analysed using Logrank tests, Cox regression models, Ranksum tests, Kruskal-Wallis tests and Kaplan-Meier curves.
RESULTS: A total of 79 patients, 36 males and 43 females, were included. Their median age was 67 years (range 36-86 years). Median survival time from surgery was 70 mo with 40.5% of patients dying before the termination date of the study. Tumours ranged from 0.8 cm in size to encompassing the entire stomach specimen, with a median tumour size of 6 cm. The median number of nodes removed at surgery was 8 with a maximum of 28. The median number of positive lymph nodes found was 2, with a range of 0 to 22. Patients' median survival time was approximately 70 mo, with 40.5% of the patients in this cohort dying before the terminal date. An increase in the incidence of cardiac tumours was noted compared to the previous 10 year interval (7.9% to 9.1%). Patients who had serosal involvement of the tumour did have a significantly shorter survival than those who did not (P = 0.017). A significant increase in the hazard ratio (HR), 2.424, for patients with circumferential tumours was found (P = 0.044). Via Kaplan-Meier estimates, the presence of venous infiltration as well as involvement of the circumferential resection margin were found to be poor prognostic markers, decreasing survival at 50 mo by 46.2% and 36.3% respectively. The increased HR for venous infiltration, 2.424, trended toward significant (P = 0.055) Age, size of tumour, number of positive nodes found and total number of lymph nodes removed were not useful predictors of survival. It is noted that the results were mostly negative, that is many tumour characteristics did not indicate any evidence of affecting patient survival. The current sample, with 30 observed events (deaths), would have about 30% power to detect a HR of 2.5.
CONCLUSION: This study mirrors pathological factors used for gastric cancer prognostication in other populations. As evaluation continues, a larger cohort will strengthen the significance of observed trends.

Entities:  

Keywords:  Cardia; Caribbean; Circumferential resection margin; Gastrectomy; Gastric adenocarcinoma; Gastritis; Helicobacter pylori; Jamaica; Pathologic; Survival

Year:  2014        PMID: 24976902      PMCID: PMC4073225          DOI: 10.4240/wjgs.v6.i6.94

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  23 in total

1.  Jamaica cancer mortality statistics, 1999.

Authors:  G Blake; B Hanchard; K Mitchell; D Simpson; N Waugh; C Wolff; E Samuels
Journal:  West Indian Med J       Date:  2002-06       Impact factor: 0.171

2.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

3.  Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry.

Authors:  J Wayman; D Forman; S M Griffin
Journal:  Cancer Causes Control       Date:  2001-12       Impact factor: 2.506

Review 4.  Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.

Authors:  Muhammed Ashraf Memon; Manjunath S Subramanya; Shahjahan Khan; Md Belal Hossain; Emma Osland; Breda Memon
Journal:  Ann Surg       Date:  2011-05       Impact factor: 12.969

5.  Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database.

Authors:  D A Corley; P A Buffler
Journal:  Int J Epidemiol       Date:  2001-12       Impact factor: 7.196

6.  Clinicopathologic profile of gastric carcinomas at the University Hospital of the West Indies.

Authors:  J M Plummer; T N Gibson; M E C McFarlane; B Hanchard; A Martin; A H McDonald
Journal:  West Indian Med J       Date:  2005-12       Impact factor: 0.171

7.  Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.

Authors:  Chun-Yan Du; Jing-Gui Chen; Ye Zhou; Guang-Fa Zhao; Hong Fu; Xue-Ke Zhou; Ying-Qiang Shi
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

8.  Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer.

Authors:  S Guadagni; G de Manzoni; M Catarci; M Valenti; G Amicucci; G De Bernardinis; C Cordiano; M Carboni; K Maruyama
Journal:  World J Surg       Date:  2000-12       Impact factor: 3.352

9.  Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program.

Authors:  E Bollschweiler; K Boettcher; A H Hoelscher; M Sasako; T Kinoshita; K Maruyama; J R Siewert
Journal:  Br J Surg       Date:  1992-02       Impact factor: 6.939

10.  Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma.

Authors:  P Edwards; G R J C Blackshaw; W G Lewis; J D Barry; M C Allison; D R B Jones
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

View more
  4 in total

1.  Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection.

Authors:  Xiaohong Wang; Yiqiang Liu; Zhaojian Niu; Runjia Fu; Yongning Jia; Li Zhang; Duanfang Shao; Hong Du; Ying Hu; Xiaofang Xing; Xiaojing Cheng; Lin Li; Ting Guo; Ziyu Li; Qunsheng Ji; Lianhai Zhang; Jiafu Ji
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

2.  Positive Helicobacter pylori status is associated with better overall survival for gastric cancer patients: evidence from case-cohort studies.

Authors:  Xuqian Fang; Kun Liu; Jialin Cai; Fangxiu Luo; Fei Yuan; Peizhan Chen
Journal:  Oncotarget       Date:  2017-06-28

Review 3.  Positive H. pylori status predicts better prognosis of non-cardiac gastric cancer patients: results from cohort study and meta-analysis.

Authors:  Zhifang Jia; Min Zheng; Jing Jiang; Donghui Cao; Yanhua Wu; Yuzheng Zhang; Yingli Fu; Xueyuan Cao
Journal:  BMC Cancer       Date:  2022-02-08       Impact factor: 4.430

4.  Impact of Surgical Margin Status on Survival in Gastric Cancer: A Systematic Review and Meta-Analysis.

Authors:  Zhiyuan Jiang; Chunyu Liu; Zhaolun Cai; Chaoyong Shen; Yuan Yin; Xiaonan Yin; Zhou Zhao; Mingchun Mu; Yiqiong Yin; Bo Zhang
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.